Brachytherapy vs Prostatectomy

Brachytherapy treats the prostate with radiation placed inside or near it, whereas prostatectomy removes the prostate through an operation.

Brachytherapy is a form of internal radiation. Depending on the plan, radioactive sources may be placed temporarily or left in the prostate to deliver treatment over time. Prostatectomy is surgery to remove the prostate and reconnect the urinary tract. Each approach has a different preparation, recovery pattern, and set of possible effects on urinary, bowel, and sexual function.

Brachytherapy may be discussed when the cancer appears confined to the prostate and its features suit a radiation-based plan. It can be used alone in some situations or combined with other treatment when the team considers that appropriate. Prostate size, urinary symptoms before treatment, previous procedures on the prostate, bowel health, imaging findings, and the cancer’s grade all help determine whether placement can be performed safely and accurately.

Prostatectomy may be considered when surgery offers a suitable way to remove cancer that is thought to be within the prostate. It may also appeal to people who want surgical pathology information after removal. The surgeon considers general fitness for anaesthesia, prior abdominal or pelvic surgery, urinary function, cancer location, and whether there are signs that cancer has extended beyond the prostate.

Both treatments can affect urinary and sexual function, but the timing and pattern can differ. Brachytherapy can cause urinary irritation, a weaker stream, urgency, bowel irritation, and fatigue. Prostatectomy can lead to urinary leakage during recovery, erectile difficulties, pain, bleeding, blood clots, infection, or narrowing where the urinary tract is rejoined. Your team can explain which effects are most relevant to your starting symptoms and planned technique.

Sometimes neither brachytherapy nor surgery is the preferred next treatment. Active surveillance may be appropriate when close monitoring is safer than immediate treatment. External-beam radiation, hormone-based treatment, other systemic medicines, or treatment directed at cancer beyond the prostate may be considered when cancer features or overall health point in a different direction. Existing urinary obstruction or bowel disease can also change which local treatment is practical.

A urologist, radiation oncologist, and other clinicians use biopsy findings, PSA trends, examination, imaging, and your health history to frame the options. They should also ask what matters most to you, such as avoiding an operation, protecting continence, preserving sexual function, travel for appointments, or having pathology from removed tissue. Bring a list of medicines and prior procedures, and ask how each choice could affect your daily activities and future treatment options.